Catalyst Capital Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-138
Closed -$28.4K – 536
2024
Q4
$28.4K Buy
138
+33
+31% +$7.24K ﹤0.01% 413
2024
Q3
$25.5K Sell
105
-2
-2% -$468 ﹤0.01% 412
2024
Q2
$23.5K Sell
107
-10
-9% -$2.17K ﹤0.01% 310
2024
Q1
$26.3K Sell
117
-7
-6% -$1.58K ﹤0.01% 301
2023
Q4
$27.3K Buy
124
+9
+8% +$1.9K ﹤0.01% 271
2023
Q3
$25.2K Buy
+115
New +$26K ﹤0.01% 307
2016
Q4
– Sell
-4,700
Closed -$344K – 517
2016
Q3
$344K Buy
+4,700
New +$332K 0.04% 231

Other funds holding STE

Catalyst Capital Advisors's STE Position: Q1 2025 in Review

Catalyst Capital Advisors sold out of Steris (STE) in Q1 2025, closing a stake of 138 shares — an estimated $28.4K sold.

Catalyst Capital Advisors first reported a position in STE in Q3 2016 and held it in 7 quarters. The position peaked at $344K in Q3 2016. 782 funds tracked by Wall St. Rank hold STE as of Q1 2025.

  • Catalyst Capital Advisors reported no remaining Steris position as of Q1 2025 after selling out during the quarter.
  • Catalyst Capital Advisors sold 138 Steris shares in Q1 2025, an estimated $28.4K.
  • Catalyst Capital Advisors first reported a position in Steris in Q3 2016 and held it in 7 quarters.
  • Catalyst Capital Advisors's Steris position peaked at $344K in Q3 2016.
  • 782 funds tracked by Wall St. Rank held Steris as of Q1 2025.

Based on Catalyst Capital Advisors's 13F filing for Q1 2025, filed 29 Apr 2025.